Bacteria:Article Title: Synthesis of acetamidosulfonamide derivatives with antioxidative and QSAR studies
Article Snippet: .. The twenty-six strains of microorganisms for the assay consisted of reference strains and clinical isolates; gram positive bacteria: Staphylococcus aureus ATCC 29213, Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATCC 12228, Enterococcus faecalis ATCC 29212, Enterococcus faecalis ATCC 33186, Micrococcus luteus ATCC 10240, Corynebacterium diphtheriae NCTC 10356, Bacillus subtilis ATCC 6633, Listeria monocytogenes , Bacillus cereus ; gram negative bacteria: Escherichia coli ATCC 25922 , Klebsiella pneumoniae ATCC 700603, Serratia marcescens ATCC 8100, Salmonella typhimurium ATCC 13311, Shewanella putrefaciens ATCC 8071, Achromobacter xylosoxidans ATCC 2706, Pseudomonas aeruginosa ATCC 27853, Pseudomonas stutzeri ATCC 17587, Shigella dysenteriae , Salmonella enteritidis , Morganella morganii , Aeromonas hydrophila , Citrobacter freundii , Plesiomonas shigelloides and diploid fungus (yeast): Candida albicans ATCC 90028, Saccharomyces cerevisiae ATCC 2601. ..
Article Title: Synthesis, biological investigation, and in silico studies of 2-aminothiazole sulfonamide derivatives as potential antioxidants
Article Snippet: .. Twenty-nine strains of microorganisms comprised of reference strains and clinical isolates were used for antimicrobial activity testing included gram positive bacteria: Staphylococcus aureus ATCC 29213, Staphylococcus aureus ATCC 25923, methicilin resistant staphylococcus aureus JCSC 3063, methicilin resistant staphylococcus aureus N315, methicilin resistant Staphylococcus aureus JCSC 4788, Staphylococcus epidermidis ATCC 12228, Enterococcus faecalis ATCC 29212, Enterococcus faecalis ATCC 33186, Micrococcus luteus ATCC 10240, Corynebacterium diphtheriae NCTC 10356, Bacillus subtilis ATCC 6633, Bacillus cereus , Listeria monocytogenes ; gram negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Serratia macescens ATCC 8100, Salmonella typhimurium ATCC 13311, Shewanella putrefaciens ATCC 8071, Achromobacter xylosoxidans ATCC 2706, Pseudomonas aeruginosa ATCC 27853, Pseudomonas stutzeri ATCC 17587, Shigella dysenteriae , Salmonella enteritidis , Morganella morganii , Aeromonas hydrophila , Citrobacter freundii , Plesiomonas shigelloides and diploid fungus (yeast): Candida albicans ATCC 90028 and Saccharomyces cerevisiae ATCC 2601. ..
Infection:Article Title: Variable Susceptibility to Gallium Compounds of Major Cystic Fibrosis Pathogens
Article Snippet: .. Achromobacter xylosoxidans ATCC 27061T Japan ns ear discharge ns [1] A. xylosoxidans CF-2 Italy 2008-2010 respiratory secretion of CF patient MDR [2] A. xylosoxidans CF-3 Italy 2008-2010 respiratory secretion of CF patient MDR [2] A. xylosoxidans CF-4 Italy 2008-2010 respiratory secretion of CF patient MDR [2] Burkholderia cenocepacia LMG 16656T UK 1989 sputum of CF patient ns [3] B. cenocepacia FFC 0076 UK ns CF patient ns This studyb Burkholderia dolosa LMG 18943T USA ns sputum of CF patient ns [4] B. dolosa FFC0305 USA ns CF patient ns This studyb Burkholderia multivorans LMG 31010T Belgium 1992 CF patient ns [5]b B. multivorans 454 Czech Republic 2002 CF patient ns This studyb Haemophilus influenzae ATCC 49247 USA 1984 sputum of a pneumonia patient ns ATCC H. influenzae ATCC 9833 USA ns CF of patient with meningitis ns ATCC H. influenzae FC 89 Italy 2004-2009 CF patient AMP, IPM [6] H. influenzae FC 104 Italy 2004-2009 CF patient ns [6] Mycobacterium abscessus ATCC 19977T USA 1953 Knee infection MDR [7] M. abscessus ISS6 Italy ns unknown MDR This studyb M. abscessus ISS7 Italy ns unknown MDR This studyb M. abscessus ISS9 Italy ns unknown MDR This studyb Pseudomonas aeruginosa ATCC 15692 (PAO1) ns ns infected wound ns ATCC P. aeruginosa TR1 Italy 2009 respiratory secretion of CF patient ns [8] P. aeruginosa FM12 Italy ns respiratory secretion of CF patient ns [9] P. aeruginosa FM13 Italy ns respiratory secretion of CF patient ns [9] Staphylococcus aureus ATCC 25923 USA 1945 human clinical ns ATCC S. aureus BG-1 Italy 2016 CF patient ns This studyb S. aureus BG-6 Italy 2016 CF patient MRSA This studyb S. aureus BG-7 Italy 2016 CF patient MRSA This studyb Stenotrophomonas maltophilia ATCC 13637T ns ns OP region of patient with mouth cancer ns ATCC S. maltophilia K279a UK ns blood of non-CF patient MDR [10] S. maltophilia OBGTC23 Italy 2003-2005 sputum of CF patient MDR [11] S. maltophilia OBGTC26 Italy 2003-2005 sputum of CF patient MDR [11] Streptococcus pneumoniae ATCC 33400T ns ns unknown ns ATCC S. pneumoniae PFC-01 Italy 2010 CF patient ns [12] S. pneumoniae PFC-02 Italy 2010 CF patient ns [12] S. pneumoniae PFC-04 Italy 2010 CF patient ns [12] a Abbreviations: ATCC, American type culture collection; AMP, ampicillin; CF, cystic fibrosis; CSF, cerebrospinal fluid; IPM, imipenem; MDR, multidrug resistant; MRSA, methicillin-resistant Staphylococcus aureus; OP, Oropharyngeal; ns, not specified. .. T type strain. b Identification of strains as member of B. cepacian complex was carried out by a triphasic analysis: (i) growth on the selective Burkholderia cepacia agar base (ThermoFisher); (ii) positive identification using the commercial system API 20NE (bioMérieux, Marcy l'Etoile, France); (iii) molecular identification by recA-PCR-Restriction Fragment Length Polymorphism as previously described13, M. abscessus was isolated on Lowenstein-Jensen solid medium and identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS, Bruker Daltonics); S. aureus strains were identified by both manual (API-STAPH System; bioMérieux, Marcy-L'Etoile, France) and automate (VITEK 2 System, bioMérieux) biochemical test-based system iii Table S2.
Clinical Proteomics:Article Title: Variable Susceptibility to Gallium Compounds of Major Cystic Fibrosis Pathogens
Article Snippet: .. Achromobacter xylosoxidans ATCC 27061T Japan ns ear discharge ns [1] A. xylosoxidans CF-2 Italy 2008-2010 respiratory secretion of CF patient MDR [2] A. xylosoxidans CF-3 Italy 2008-2010 respiratory secretion of CF patient MDR [2] A. xylosoxidans CF-4 Italy 2008-2010 respiratory secretion of CF patient MDR [2] Burkholderia cenocepacia LMG 16656T UK 1989 sputum of CF patient ns [3] B. cenocepacia FFC 0076 UK ns CF patient ns This studyb Burkholderia dolosa LMG 18943T USA ns sputum of CF patient ns [4] B. dolosa FFC0305 USA ns CF patient ns This studyb Burkholderia multivorans LMG 31010T Belgium 1992 CF patient ns [5]b B. multivorans 454 Czech Republic 2002 CF patient ns This studyb Haemophilus influenzae ATCC 49247 USA 1984 sputum of a pneumonia patient ns ATCC H. influenzae ATCC 9833 USA ns CF of patient with meningitis ns ATCC H. influenzae FC 89 Italy 2004-2009 CF patient AMP, IPM [6] H. influenzae FC 104 Italy 2004-2009 CF patient ns [6] Mycobacterium abscessus ATCC 19977T USA 1953 Knee infection MDR [7] M. abscessus ISS6 Italy ns unknown MDR This studyb M. abscessus ISS7 Italy ns unknown MDR This studyb M. abscessus ISS9 Italy ns unknown MDR This studyb Pseudomonas aeruginosa ATCC 15692 (PAO1) ns ns infected wound ns ATCC P. aeruginosa TR1 Italy 2009 respiratory secretion of CF patient ns [8] P. aeruginosa FM12 Italy ns respiratory secretion of CF patient ns [9] P. aeruginosa FM13 Italy ns respiratory secretion of CF patient ns [9] Staphylococcus aureus ATCC 25923 USA 1945 human clinical ns ATCC S. aureus BG-1 Italy 2016 CF patient ns This studyb S. aureus BG-6 Italy 2016 CF patient MRSA This studyb S. aureus BG-7 Italy 2016 CF patient MRSA This studyb Stenotrophomonas maltophilia ATCC 13637T ns ns OP region of patient with mouth cancer ns ATCC S. maltophilia K279a UK ns blood of non-CF patient MDR [10] S. maltophilia OBGTC23 Italy 2003-2005 sputum of CF patient MDR [11] S. maltophilia OBGTC26 Italy 2003-2005 sputum of CF patient MDR [11] Streptococcus pneumoniae ATCC 33400T ns ns unknown ns ATCC S. pneumoniae PFC-01 Italy 2010 CF patient ns [12] S. pneumoniae PFC-02 Italy 2010 CF patient ns [12] S. pneumoniae PFC-04 Italy 2010 CF patient ns [12] a Abbreviations: ATCC, American type culture collection; AMP, ampicillin; CF, cystic fibrosis; CSF, cerebrospinal fluid; IPM, imipenem; MDR, multidrug resistant; MRSA, methicillin-resistant Staphylococcus aureus; OP, Oropharyngeal; ns, not specified. .. T type strain. b Identification of strains as member of B. cepacian complex was carried out by a triphasic analysis: (i) growth on the selective Burkholderia cepacia agar base (ThermoFisher); (ii) positive identification using the commercial system API 20NE (bioMérieux, Marcy l'Etoile, France); (iii) molecular identification by recA-PCR-Restriction Fragment Length Polymorphism as previously described13, M. abscessus was isolated on Lowenstein-Jensen solid medium and identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS, Bruker Daltonics); S. aureus strains were identified by both manual (API-STAPH System; bioMérieux, Marcy-L'Etoile, France) and automate (VITEK 2 System, bioMérieux) biochemical test-based system iii Table S2.
other:
Article Title: Genomic Potential of Bioaugmentation with Microbial N2O Reductase for Greenhouse Gas Mitigation
Article Snippet: Consistently, in our study, no pathogenicity was identified in previously studied microorganisms such as Pseudomonas stutzeri DCP-Ps1, Pseudomonas stutzeri PCN-1, Paracoccus denitrificans, Bradyrhizobium diazoefficiens, Sinorhizobium meliloti 1021, Achromobacter cycloclastes ATCC 21921 = IAM 1013, Azospira sp. I13, and Anaeromyxobacter dehalogenans 2CP-C.
Activity Assay:Article Title: Synthesis, biological investigation, and in silico studies of 2-aminothiazole sulfonamide derivatives as potential antioxidants
Article Snippet: .. Twenty-nine strains of microorganisms comprised of reference strains and clinical isolates were used for antimicrobial activity testing included gram positive bacteria: Staphylococcus aureus ATCC 29213, Staphylococcus aureus ATCC 25923, methicilin resistant staphylococcus aureus JCSC 3063, methicilin resistant staphylococcus aureus N315, methicilin resistant Staphylococcus aureus JCSC 4788, Staphylococcus epidermidis ATCC 12228, Enterococcus faecalis ATCC 29212, Enterococcus faecalis ATCC 33186, Micrococcus luteus ATCC 10240, Corynebacterium diphtheriae NCTC 10356, Bacillus subtilis ATCC 6633, Bacillus cereus , Listeria monocytogenes ; gram negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Serratia macescens ATCC 8100, Salmonella typhimurium ATCC 13311, Shewanella putrefaciens ATCC 8071, Achromobacter xylosoxidans ATCC 2706, Pseudomonas aeruginosa ATCC 27853, Pseudomonas stutzeri ATCC 17587, Shigella dysenteriae , Salmonella enteritidis , Morganella morganii , Aeromonas hydrophila , Citrobacter freundii , Plesiomonas shigelloides and diploid fungus (yeast): Candida albicans ATCC 90028 and Saccharomyces cerevisiae ATCC 2601. ..
|
ATCC is a verified supplier 
ATCC manufactures this product 